Por: The Hill Health November 04, 2022
Pfizer and BioNTech have launched a phase 1 trial for an mRNA-based vaccine that would target both COVID-19 and the influenza virus. , the vaccine candidate is a combination of Pfizer’s flu vaccine candidate, which is in phase 3 clinical development, and the company’s bivalent omicron-specific coronavirus vaccine dose. As COVID-19 vaccines have become widely available, discussion has arisen over the possibility of a combined flu and... + full article
ABC News USA Health November 04, 2022
Pfizer and BioNTech have launched a clinical trial on a vaccine targeting both COVID-19 and influenza, the companies Thursday.The phase 1 trial is being done in the United States with 180 participants between the ages of 18 and 64, with the first participant dosed this week, the... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
CNBC USA Health November 02, 2022
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más
Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC
Pfizer climbs on strong Q3 results, raised outlook | MarketWatch
CNN USA Health October 29, 2022
CNN — Flu season has ramped up early in the United States, and flu hospitalizations are worse than usual for this time of year, according to published Friday by the US Centers for Disease Control and Prevention. It’s been more than a decade – since the H1N1 swine flu... + más
‘Do I have to get a flu shot?’ Your flu questions answered | Orlando Sentinel
Sheldon Jacobson and Janet Jokela: Will we have a severe flu season? It doesn’t need to be that way. | Chicago Tribune
Fox Business USA Business October 22, 2022
Fox News contributor Dr. Janette Nesheiwat discusses Pfizer’s new anti-viral COVID-19 pill and the importance of early treatment. has revealed the price it is eyeing in the U.S. for its adult COVID-19 vaccine on the commercial market. Ticker Security Last Change Change %... + más
Pfizer says COVID-19 vaccine will cost $110-$130 per dose | ABC News
The Advocate USA Crime October 10, 2022
vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
WPTV USA Nation October 07, 2022
This flu season is expected to be more intense than the past few seasons.“This upcoming flu season is not going to be like the past two flu seasons which were virtually non-existent because of all the social distancing and mask wearing,” Dr. Amesh Adalja, a senior scholar at... + más
It’s flu vaccine time and seniors need revved-up shots | Portland Press Herald
It’s flu vaccine time and seniors need revved-up shots | WGN-TV
Chicago Tribune USA Opinion September 26, 2022
Flu season is fast approaching. Flu shots are now available, containing strains recommended by the Food and Drug Administration’s vaccine advisory committee in March. Given the long lead time required to manufacture some 180 million flu shot doses, scientists are forced to... + más
October the best time to get COVID boosters, flu shots, experts say | ABC News
When’s the Perfect Time to Get a Flu Shot? | The Atlantic
About iurex | Privacy Policy | Disclaimer |